MRW Leadership Board Hosts 3rd Annual ‘Jammin’ in Our Genes’ Benefit on Dec. 1

3rd Annual ‘Jammin’ in Our Genes’ Benefit to Support Mammography Screening Program for Uninsured, Underserved Patients

The Myra Rubenstein Weis (MRW) Leadership Board will host their third annual “Jammin’ in Our Genes” event benefitting NorthShore University HealthSystem on Saturday, Dec. 1. Proceeds from this year’s event will support a mammography screening program for the uninsured and underserved at NorthShore Health Clinic Highland Park in 2019.

The “Jammin’ in Our Genes” benefit will take place at 210 Restaurant (210 Green Bay Road, Highwood) on Saturday, Dec. 1 from 8-11 p.m. This year’s benefit will include a silent auction, games, music provided by DJ Versage, drinks, desserts, and more. Tickets are $60 online, or $75 at the door. For tickets or to make a donation, visit

As the event approaches its third year, event co-chairs Stephanie and Jordan Goldstein, MD, Caryn Engle, and Ari Goldsmith celebrate the milestones already achieved, with support of the community. The group began with their focus on those genetically predisposed to breast and ovarian cancers, carrying the BRCA genes. They quickly realized that while they could educate patients on their risks, those who were carrying the gene may not have access to the resources they needed.

“Breast and ovarian cancer education and prevention are important to us on a very personal level. We are humbled by the support and commitment from our friends, our family, our neighbors, and local businesses,” says Engle. “As a BRCA patient and PreVivor, I know first-hand the importance of mammography to high-risk women, and together we are providing life-saving resources to hundreds of women in Lake County.”

Myra Rubenstein Weis (MRW) Leadership Board
Front, L to R: Jamie Engle, Sara Franklin; Back, L to R: Nancy Blitz, Debbie Ori, Caryn Engle, Stephanie Goldstein, Jordan Goldstein, Ari Goldsmith, Heather Redisch, Lindsey Goldstein Ross

One common misconception about the BRCA genes is that only women are at risk, says Peter Hulick, MD, director of the Center for Personalized Medicine, NorthShore University HealthSystem. “Knowing one has a mutation in BRCA1 or BRCA2 is important for females and males. If a patient has a BRCA mutation, changes in screening are recommended (earlier screening and addition of other modalities like breast MRI), and preventative options are considered. It also allows us to have a better understanding of the disease course. For example, BRCA2 related prostate cancer is more aggressive, and more likely to become metastatic,” Dr. Hulick explains.

About the MRW Leadership Board

The Myra Rubenstein Weis (MRW) Leadership Board’s goal is to educate and empower people to make informed decisions to prevent hereditary breast and ovarian cancers.  Funds raised through their activities support Living in the Future (LIFE) Pre-Vivor resources. These resources are in line with the MRW Leadership Board Previvor mission to prevent breast cancer in those predisposed to it, and to make available resources and strategies, in conjunction with NorthShore University HealthSystem, by supporting a mammography screening program for the uninsured and underserved at NorthShore Health Clinic Highland Park in 2019. The MRW Leadership Board is an extension of the MRW Health Resource Center Benefit Committee that supports NorthShore wellness and cancer survivorship programs. Both were established to honor Myra Rubenstein Weis and her service to the Highland Park community.